Neekesh V Dharia

25PUBLICATIONS
223CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

D Bennett, M Wierdl, S Chakraborty

|Jul 09, 2025
Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Adrian G Sacher, Wilson H Miller, Manish R Patel

|Jul 18, 2024
Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia.

Constanze Schneider, Hermes Spaink, Gabriela Alexe

|Jul 12, 2024
Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors.

Yoonha Choi, Neekesh V Dharia, Tomi Jun

|Dec 05, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.

Jayesh Desai, Guzman Alonso, Se Hyun Kim

|Aug 23, 2023
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.

Adrian Sacher, Patricia LoRusso, Manish R Patel

Pageof 5

Frequent Collaborators

9 joint publications

Kimberly Stegmaier

8 joint publications

Francisca Vazquez

7 joint publications

Aviad Tsherniak

5 joint publications

William C Hahn